Ethicon Gains PMA For SEDASYS; Opens New Opportunity In GI Medicine
Executive Summary
Ethicon finally received FDA approval in May for its SEDASYS System, a computer-assisted personalized sedation system that allows physician-led teams to safely administer the anesthetic agent propofol during certain gastroenterology procedures, including colonoscopy. The approval opens up a whole new product category for the company with a market potential of 15 million procedures in the US alone.
You may also be interested in...
Six Devices, Diagnostics Among Cleveland Clinic’s Top 10 Innovations For 2014
At its October Medical Innovation Summit, the Cleveland Clinic unveiled six device and diagnostics products that were selected for inclusion in its list of top 10 innovations for 2014.
Six Devices, Diagnostics Among Cleveland Clinic’s Top 10 Innovations
At its 2013 Innovation Summit, the Cleveland Clinic unveiled six devices and diagnostics among its top 10 innovations.
J&J Gets Second Chance At Sedasys Sedation Device Approval
Johnson & Johnson subsidiary Ethicon Endo-Surgery has received a go-ahead from the FDA commissioner's office to embark on a rarely used process to appeal a PMA denial by the agency’s device center.